分享好友 环球市场首页 环球市场分类 切换频道

Radiotherapy Market

2024-09-2300

Report Overview

The Global Radiotherapy Market size is expected to be worth around USD 12.1 Billion by 2033 from USD 6.8 Billion in 2023, growing at a CAGR of 5.9% during the forecast period from 2023 to 2032.

Radiotherapy is a cancer treatment that uses high doses of radiation to destroy cancer cells and shrink’s tumors. Radiotherapy is essential in cancer treatment and improves cancer patient survival rates. In addition, it is commonly used with other cancer treatments, such as surgery and chemotherapy. The market is increasing owing to the rising prevalence of cancer advances in technology and investment in cancer research.

Radiotherapy Market Growth

Key Takeaways

Driving Factors

Technological Developments in Radiotherapy to Drive the Market Growth

Technological developments in radiotherapy products, a rising geriatrics population, an increasing prevalence of cancer cases across the globe, increasing symposiums, increasing approval of radiotherapy devices, and compelling investments in radiotherapy will drive the radiotherapy market.

A few other factors fueling this market growth are the rising preference for non-surgical processes and the requirement for replacement, as hospitals are replacing older equipment with novel therapy systems that deal with better facilities. In addition, the increasing geriatric population is the primary factor propelling the market growth.

Restraining Factors

High Cost of Radiotherapy Treatment

The cost of radiotherapy is high, which causes patients to look for other treatment modes, thus hindering market growth. As a result, the global radiotherapy market growth is restricted. Furthermore, the limited healthcare expenditure in developing countries causes the low installation of radiotherapy devices.

Growth Opportunities

Growing Public-Private Investments in Cancer Research

Rising public-private investments and funding for cancer research to bring in advancements in the diagnosis and treatments of cancer is one of the main factors supporting the growth of the global market.

Currently, several countries are raising their expenditure in the healthcare sector to allow more individuals access to better facilities. This could increase the radiotherapy equipment requirement, propelling the market growth.

Trending Factors

Recent Innovations in Radiotherapy Market

Recent inventions in radiotherapy have enhanced effective treatments, resulting in adverse effects and improved outcomes. Significant developments are observed in practical therapy, stereotactic body radiation therapy, and intensity-modulated radiation therapy. One of the main developments is the advent of adaptive radiation therapy treatment, which can be adjusted to improve patient outcomes.

Since the features of tumors and patients change during the treatment course. The increasing requirement for cancer and the rise in demand for advanced cancer treatments, such as chemotherapy and radiotherapy, are among the main factors driving market growth in the upcoming years.

Therapy Type Analysis

External Beam Radiation Therapy Segment to Witness Significant Growth

Based on therapy type, the global radiotherapy market is segmented into external beam radiation therapy, internal beam radiation therapy, and systemic radiation therapy.

In 2023, The external beam radiotherapy segment accounted for the largest market revenue share of 77.5% during the forecast period. Due to the accuracy of the directed beam at the cancerous cells, thus causing less destruction to normal tissues, tolerating oncologists use advanced disease radiotherapy for treatment and rise in the cancer population.

In addition, an increase in awareness among individuals regarding the novel and advanced methods for radiotherapy is also anticipated to drive segmental growth.

Application Analysis

Prostate Cancer Segment Dominates the Market

Based on application, the global radiotherapy market is divided into prostate cancer, breast cancer, lung cancer, head and neck cancer, colorectal cancer, gynecological cancer, cervical cancer, penile cancer, prostate cancer, liver cancer, spine cancer, thyroid cancer, bladder cancer, lip cancer, and other cancers.

In 2023, The prostate cancer segment registers the 18.3% market revenue share during the forecast period. Owing to the large number of patients suffering from prostate tumors worldwide. Studies have found that radiation therapy, used to kill cancerous cells in the prostate gland, is as effective as surgery. It also removes the adverse effects associated with surgical processes. Therefore, rising patient dominance for radiotherapy over conventional processes will favor industry growth. However, the breast cancer segment registers the fastest market growth revenue share during the forecast period.

The demand for radiotherapy market growth in the upcoming years is due to the increase in the incidence of breast cancers. In addition, the rising use of advanced technologies such as image-guided therapy, intensity-modulated radiotherapy, and others. However, the growing investment in improving innovative radiotherapy products and increasing awareness about breast cancer and its treatments are anticipated to boost the market growth further.

End-User Analysis

The Hospitals & Diagnostic Laboratories Segment Dominated the Highest Market Growth

Based on end-users, the global radiotherapy market is divided into hospitals & diagnostic laboratories, cancer treatment & research centers, academic research organizations, ambulatory surgery centers, and others.

In 2023, The hospitals & diagnostic laboratories segment dominated the market revenue share of 51.8% in 2022. Commonly, hospitals are well prepared with radiotherapy units to provide the several need for radiotherapy methods.

Hospitals and diagnostics laboratories are used to treat variations of cancerous tumors as a part of adjuvant therapy to prevent the reappearance of tumors after surgery and remove a primary malignant tumor. The cancer research institutes segment is anticipated to exhibit the highest CAGR of 4.3%. Cancer research institutes rapidly install advanced radiotherapy devices to provide advanced and effective patient care.

Radiotherapy Market Size

Key Market Segments

By Therapy Type

By Application

By End-User

Regional Analysis

North America Region Accounted Significant Share of the Global Radiotherapy Market.

In 2023, North America accounted for a significant radiotherapy market revenue share of 43.3% and holds USD 2.9 Billion market value for the year. Owing to the rising investments in developing novel devices in healthcare. Additionally, the increasing dominance of the rate of rare diseases across North America also influences the market requirements. Factors such as recognized radiotherapy system providers and the replacement of old therapies with novel ones fueling the regional demand for market growth.

Europe held the second-largest market revenue share during the forecast period, and the market players are fueling the requirements for the radiotherapy market during the forecast period. The Asia-Pacific region is anticipated to witness the maximum revenue share due to the introduction of novel radiotherapy in healthcare centers and hospitals in developing countries.

Radiotherapy Market Regions

Key Regions

Key Players Analysis

Key market players use strategies such as collaborations, mergers & acquisitions, and partnerships to maintain their position in the market. Several companies in the radiotherapy industry include Varian Medical Systems, Inc., Elekta AB, Accuracy Incorporated, Hitachi, Ltd, Siemens Healthineers AG, and other key players. The following are some of the major players in the global radiotherapy market industry

Key Market Players

Recent Developments

点赞 0
举报
收藏 0
评论 0
分享 0